Get Free Demat Account*
Open Your Free Demat Account
Enjoy low brokerage on delivery trades
By Dalal Street Investment Journal (DSIJ)
Bank of Baroda settled its legal dispute with NMC Health, NMC Healthcare and NMC Holding for $600 million (around ₹5,700 crore), bringing insolvency proceedings in Abu Dhabi and England & Wales to a close.
Baroda Bank share price was at ₹260.25 on July 2, 2026, after registering a decline of 4.20% from the previous day’s close. There was a high of ₹273.50 and a low of ₹257.70. There were 261 lakh shares recorded, while there is an average daily volume of 142 lakh shares in the last thirty days, with turnover running nearly twice the norm following a significant announcement.
Bank of Baroda disclosed on 2 July, 2026 that it has settled out of court with the joint administrators of NMC Health PLC, NMC Healthcare Ltd and NMC Holding Ltd. The amount involved in this case is $600 million or ₹5,700 crore and has been paid by the Abu Dhabi branch of Bank of Baroda.
The multi-year dispute stemmed from cross-border insolvency lawsuits filed across two separate jurisdictions. These lawsuits had been brought before the ADGM Court of First Instance and the High Court of Justice of England and Wales. The lawsuits were brought by the companies NMC Healthcare Ltd., NMC Holding Ltd and NMC Health PLC on behalf of their joint administrators, Richard Fleming and Benjamin Cairns, against Dr. B.R. Shetty, Prasanth Manghat and Bank of Baroda.
The cases involved proceedings under ADGM and UK insolvency law, UAE civil law and related matters concerning NMC Health PLC, NMC Healthcare Ltd and NMC Holding Ltd. The ADGM trial commenced on March 23, 2026, while the English proceedings were stayed pending the outcome of the Abu Dhabi proceedings.
Under the settlement agreement, NMC Health PLC, NMC Healthcare Ltd, NMC Holding Ltd and their respective joint administrators have resolved all claims between them and Bank of Baroda in consideration for the payment of $600 million by the bank.
All other aspects of the settlement remain confidential and the liability of the bank in this matter is limited to the settlement amount. Since the agreement has been signed, the proceedings for ADGM have come to an end and the proceedings in England are also coming to an end.
As per the statement provided by Bank of Baroda, the purpose of the settlement was to resolve the disputes without litigation that would be costly both in terms of time and money. Settlements of such kind in complicated cross-border insolvency cases are quite common, especially when the other alternative is litigation for many years ahead.
Bank of Baroda is engaged in providing various services, such as personal banking, corporate banking, international banking, small and medium enterprise (SME) banking, rural banking, non-resident Indian (NRI) services and treasury services.
NMC Health was one of the largest private healthcare providers in the UAE before its collapse in 2020 following the discovery of significant financial irregularities. The group went into administration in the UK and the Abu Dhabi Global Market after disclosures of undisclosed debt and alleged fraud. Bank of Baroda, along with several other banks, was among the creditors and parties named in proceedings arising from the group's insolvency.
Bank of Baroda's $600 million settlement with the joint administrators of the NMC Health group brings to a close a long-running legal matter that had been before courts in two jurisdictions. The bank emphasised that the settlement involves no admission of liability or wrongdoing. With the ADGM proceedings discontinued and the English claims being wound down, the resolution removes a major long-term legal overhang from the lender's balance sheet, though the financial impact of the payment will be reflected in the relevant reporting period.
Source: Dalal Street Investment Journal (DSIJ), BSE, NSE
SEBI Registered Research Analyst (INH000006396).
Founded in 1986, Dalal Street Investment Journal (DSIJ) brings decades of experience in India’s equity markets. DSIJ's research combines fundamental analysis with price action, guided by disciplined risk management and capital preservation. They follow a structured, data-driven approach designed to help investors and traders make informed decisions beyond short-term market noise.
Disclaimer :
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited
This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading